Vantage Financial Partners (Wisconsin)’s Gilead Sciences GILD Stock Holding History

Vantage Financial Partners (Wisconsin)’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-9,249	Closed	-$713K	–	91
2023 Q2	$713K	Buy	9,249 +86	+0.9%	+$6.86K	0.27%	29
2023 Q1	$760K	Buy	9,163 +646	+8%	+$53.5K	0.3%	29
2022 Q4	$731K	Sell	8,517 -5,928	-41%	-$469K	0.44%	20
2022 Q3	$9K	Buy	14,445 +166	+1%	+$10.5K	0.01%	59
2022 Q2	$883K	Buy	14,279 +163	+1%	+$10.1K	0.52%	15
2022 Q1	$839K	Buy	14,116 +173	+1%	+$11.1K	0.43%	17
2021 Q4	$1.01M	Buy	+13,943	New	+$960K	0.4%	21

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vantage Financial Partners (Wisconsin)'s GILD Position: Q3 2023 in Review

Vantage Financial Partners (Wisconsin) sold out of Gilead Sciences (GILD) in Q3 2023, closing a stake of 9,249 shares — an estimated $713K sold.

Vantage Financial Partners (Wisconsin) first reported a position in GILD in Q4 2021 and held it in 7 quarters. The position peaked at $1.01M in Q4 2021. 1,682 funds tracked by Wall St. Rank hold GILD as of Q3 2023.

Vantage Financial Partners (Wisconsin) reported no remaining Gilead Sciences position as of Q3 2023 after selling out during the quarter.
Vantage Financial Partners (Wisconsin) sold 9,249 Gilead Sciences shares in Q3 2023, an estimated $713K.
Vantage Financial Partners (Wisconsin) first reported a position in Gilead Sciences in Q4 2021 and held it in 7 quarters.
Vantage Financial Partners (Wisconsin)'s Gilead Sciences position peaked at $1.01M in Q4 2021.
1,682 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2023.

Based on Vantage Financial Partners (Wisconsin)'s 13F filing for Q3 2023, filed 2 Nov 2023.